MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells

(2012) Zhigang Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor

(2012) Ke Shen et al.   BIOCHEMICAL PHARMACOLOGY

Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway

(2012) Longqiu Yang et al.   BIOMEDICINE & PHARMACOTHERAPY

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

(2012) S E Jalava et al.   ONCOGENE

MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis

(2011) E. Gocek et al.   CANCER RESEARCH

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells

(2011) Lifen Wu et al.   FEBS LETTERS

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

(2010) Gui Hu et al.   CANCER BIOLOGY & THERAPY

Clinical significance of tumor suppressor PTEN in colorectal carcinoma

(2010) C.P. Hsu et al.   EJSO

MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1

(2010) Stuart Hunt et al.   FEBS LETTERS

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

(2010) Changzheng Liu et al.   JOURNAL OF HEPATOLOGY

miR-24 up-regulation in oral carcinoma: Positive association from clinical and in vitro analysis

(2010) Shu-Chun Lin et al.   ORAL ONCOLOGY

Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states

(2009) Aaron L Sarver et al.   BMC CANCER

PI 3-kinase and cancer: changing accents

(2009) Peter K Vogt et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma

(2009) Ki-Seok Jang et al.   HISTOPATHOLOGY

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

(2009) T. Moriyama et al.   MOLECULAR CANCER THERAPEUTICS

Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?

(2008) Tamer Colakoglu et al.   AMERICAN JOURNAL OF SURGERY

RISC-target interaction: Cleavage and translational suppression

(2008) A VANDENBERG et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival

(2008) Hirozumi Sawai et al.   BMC GASTROENTEROLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

(2008) M. Jhawer et al.   CANCER RESEARCH

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells

(2008) Antonio Strillacci et al.   EXPERIMENTAL CELL RESEARCH

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma

(2008) Aaron J. Schetter et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

(2008) L S Steelman et al.   LEUKEMIA

Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

(2008) D Bhaumik et al.   ONCOGENE